Solventum appoints Heather Knight as Chief Commercial Officer; Chris Barry to depart

Solventum Corp

Heather Knight appointed to new Chief Commercial Officer role effective Nov 10, 2025, overseeing MedSurg, Dental, Health Information Systems.
Ms. Knight previously COO at Baxter International; brings 30+ years MedTech leadership.
Chris Barry, EVP & Group President of MedSurg, will depart Dec 31, 2025, and receive severance under the Solventum Executive Severance Plan.
Knight will report directly to CEO Bryan Hanson.
Barry's outstanding equity awards will be treated per applicable agreements and Severance Plan.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.